|
IQVIA™ Real-World Insights Bibliography
| Épidémiologie et mortalité de la pneumopathie interstitielle diffuse de forme progressive (hors fibrose pulmonaire idiopathique): données du Système National des Données de Santé–Étude PROGRESS |
| Author(s): M.Nasser, P.Rabiega, L.Boussel, S.Si Mohamed, V.Barbet, S.Marque, J.Massol, F.Thivolet-Bejui, L.Chalabreysse, D.Maucort Boulch, E.Hachulla, S.Jouneau, K.Le La, V.Cottin |
| Affiliations(s): 1 Hospices civils de Lyon, Lyon, France
2 IQVIA-RWS, La Défense, France
3 AIXIAL, Paris, France
4 CHU, Lille, France
5 CHU, Rennes, France
6 Boehringer Ingelheim France, Paris, France |
Publication(s): https://doi.org/10.1016/j.rmra.2020.11.023
|
| Document Type(s): Article, |
| Countries: France, |
| Click here for the abstract |
C:
Y: |
Respiratory disease,
2021 |
|
L:
A: |
French
Methodology, Population Based Study, |
|
 |
| |
| |
| Progressive fibrosing interstitial lung disease: a clinical cohort (the PROGRESS study). |
| Author(s): Mouhamad Nasser, Sophie Larrieu, Salim Si-Mohamed, Kaïs Ahmad, Loic Boussel, Marie Brevet, Lara Chalabreysse, Céline Fabre, Sébastien Marque, Didier Revel, Françoise Thivolet-Bejui, Julie Traclet, Sabrina Zeghmar, Delphine Maucort-Boulch, Vincent Cottin |
| Affiliations(s): 1 Dept of Respiratory Medicine, National Coordinating Reference Centre for Rare Pulmonary Diseases, OrphaLung, Louis Pradel Hospital, University Hospital of Lyon, Lyon, France
2 Claude Bernard University Lyon 1, UMR754 INRAE, IVPC, Lyon, France
3 IQVIA, La Défense, France
4 Dept of Radiology, University Hospital of Lyon, Lyon, France
5 Dept of Pathology, University Hospital of Lyon, Lyon, France
6 CYPATH, Villeurbanne, France
7 Dept of Biostatistics, University Hospital of Lyon, Lyon, France |
Publication(s): Eur Respir J
. 2021 Feb 11;57(2):2002718. doi: 10.1183/13993003.02718-2020.
|
| Document Type(s): Abstract, |
| Countries: France, |
| Click here for the abstract |
C:
Y: |
Respiratory disease,
2021 |
|
L:
A: |
English
Observational study, Population Based Study, |
|
|
| |
| |
| Estimates of epidemiology, mortality and disease burden associated with progressive fibrosing interstitial lung disease in France (the PROGRESS study) |
| Author(s): Mouhamad Nasser, Sophie Larrieu, Loic Boussel, Salim Si-Mohamed, Fabienne Bazin, Sébastien Marque, Jacques Massol, Françoise Thivolet-Bejui, Lara Chalabreysse, Delphine Maucort-Boulch, Eric Hachulla, Stéphane Jouneau, Katell Le Lay & Vincent Cottin |
| Affiliations(s): 1 Hôpital Louis Pradel, Centre National de Référence des Maladies Pulmonaires Rares, Hospices Civils de Lyon, Lyon, OrphaLung, RespiFil, ERN-LUNG, Claude Bernard University Lyon 1, 28 Avenue du Doyen Lepine, 69677, Lyon Cedex, France.
2 UMR754, INRAE, Université Claude Bernard Lyon 1, Lyon, France.
3 IQVIA, RWS - La Défense, Paris, France.
4 Département de Radiologie, Hospices Civils de Lyon, Lyon, France.
5 CNRS, Inserm, CREATIS UMR 5220, Université de Lyon, INSA-Lyon, University Claude Bernard Lyon 1, UJM-Saint Etienne, Lyon, France.
6 AIXIAL, Boulogne-Billancourt, France.
7 Département d'anatomo-pathologie, Hospices Civils de Lyon, Lyon, France.
8 Université de Lyon, 69000, Lyon, France.
9 Université de Lyon 1, 69100, Villeurbanne, France.
10 Service de Biostatistique et Bioinformatique, Hospices Civils de Lyon, Pôle Santé Publique, 69003, Lyon, France.
11 CNRS, UMR 5558, Équipe Biostatistique-Santé, Laboratoire de Biométrie et Biologie Évolutive, 69100, Villeurbanne, France.
12 Service de Médecine Interne et Immunologie Clinique, Hôpital Claude Huriez, Centre National de Référence des maladies auto‑immunes systémiques rare du Nord et Nord‑Ouest de France (CeRAINO), CHU de Lille, Lille, France.
13 Centre Hospitalier Universitaire de Rennes, Centre de Compétences pour les Maladies Pulmonaires Rares, Inserm, EHESP, IRSET (Institut de recherche en santé, environnement et travail), RespiFil, OrphaLung, Univ Rennes, Rennes, France.
14 Boehringer Ingelheim France SAS, Paris, France.
15 Hôpital Louis Pradel, Centre National de Référence des Maladies Pulmonaires Rares, Hospices Civils de Lyon, Lyon, OrphaLung, RespiFil, ERN-LUNG, Claude Bernard University Lyon 1, 28 Avenue du Doyen Lepine, 69677, Lyon Cedex, France. vincent.cottin@chu-lyon.fr.
16 UMR754, INRAE, Université Claude Bernard Lyon 1, Lyon, France. vincent.cottin@chu-lyon.fr. |
Publication(s): Respir Res
. 2021 May 24;22(1):162. doi: 10.1186/s12931-021-01749-1.
|
| Document Type(s): Abstract, |
| Countries: France, |
| Click here for the abstract |
C:
Y: |
Respiratory disease,
2021 |
|
L:
A: |
English
Methodology, Observational study, |
|
|
| |
| |
| Epidemiology, Mortality and Healthcare Resource Utilization Associated With Systemic Sclerosis-Associated Interstitial Lung Disease in France |
| Author(s): Vincent Cottin 1, Sophie Larrieu 2, Loic Boussel 3 4, Salim Si-Mohamed 3 4, Fabienne Bazin 2, Sébastien Marque 2, Jacques Massol 5, Françoise Thivolet-Bejui 6, Lara Chalabreysse 6, Delphine Maucort-Boulch 7 8 9 10, Stéphane Jouneau 11, Eric Hachulla 12, Julien Chollet 13, Mouhamad Nasser 1 |
| Affiliations(s): 1 Hôpital Louis Pradel, Centre Coordonnateur National de Référence des Maladies Pulmonaires Rares, Hospices Civils de Lyon, UMR754 INRAE and Université Claude Bernard Lyon 1, Member of ERN-LUNG, RespiFil, OrphaLung, Lyon, France.
2 IQVIA - RWS La Défense, Courbevoie, France.
3 Département de Radiologie, Hospices Civils de Lyon, Lyon, France.
4 Université Lyon, INSA-Lyon, Université Claude Bernard Lyon 1, UJM-Saint Etienne, CNRS Inserm, CREATIS UMR 5220, Lyon, France.
5 AIXIAL - Paris, Paris, France.
6 Département d'anatomo-pathologie, Hospices Civils de Lyon, Lyon, France.
7 Hospices Civils de Lyon, Pôle Santé Publique, Service de Biostatistique et Bioinformatique, Lyon, France.
8 Université de Lyon, Lyon, France.
9 Université Lyon 1, Villeurbanne, France.
10 CNRS, UMR 5558, Laboratoire de Biométrie et Biologie Évolutive, Équipe Biostatistique-Santé, Villeurbanne, France.
11 Centre Hospitalier Universitaire de Rennes, Centre de Compétences pour les Maladies Pulmonaires Rares, Univ Rennes, Inserm, EHESP, IRSET (Institut de recherche en santé, environnement et travail), RespiFil, OrphaLung, Rennes, France.
12 Hôpital Claude Huriez, Centre National de Référence des maladies auto-immunes systémiques rares (CeRAINO), CHU de Lille, Lille, France.
13 Boehringer Ingelheim France SAS, Paris, France. |
Publication(s): Front Med (Lausanne)
. 2021 Aug 30;8:699532. doi: 10.3389/fmed.2021.699532.
|
| Document Type(s): Abstract, |
| Countries: France, |
| Click here for the abstract |
C:
Y: |
Immunology and Vaccination, Respiratory disease,
2021 |
|
L:
A: |
English
Observational study, Population Based Study, |
|
|
| |
| |
| Impact des nouveaux traitements (AAD) de l’hépatite C dans la population générale et les populations à risque : étude réalisée en France à partir des données du SNDS sur la période 2015-2019 |
| Author(s): PascalineRabiéga1, StanislasPol2, FayssoilFouad1, IngridRodriguez3, OlivierLada3, MagaliLemaitre1, EliasBenabadji3, FrançoiseRoudot-Thoraval4 |
| Affiliations(s): 1 IQVIA, Courbevoie, France
2 Cochin (AP-HP), Paris, France
3 Gilead Sciences, Boulogne Billancourt, France
4 Henri-Mondor (AP-HP), Créteil, France |
Publication(s): https://doi.org/10.1016/j.respe.2021.05.010
|
| Document Type(s): Article, |
| Countries: France, |
| Click here for the abstract |
C:
Y: |
Immunology and Vaccination, Infectious disease,
2021 |
|
L:
A: |
French
Methodology, Population Based Study, |
|
|
| |
| |
| Ability of primary care health databases to assess medicinal products discussed by the European Union Pharmacovigilance Risk Assessment Committee |
| Author(s): Robert Flynn1,2,*, Karin Hedenmalm1, Tarita Murray-Thomas3, Alexandra Pacurariu1, Peter Arlett1, Hilary Shepherd3, Puja Myles3, Xavier Kurz1 |
| Affiliations(s): 1 Pharmacovigilance and Epidemiology Department, European Medicines Agency, Amsterdam, The
Netherlands
2 Medicines Monitoring Unit (MEMO), Division of Molecular and Clinical Medicine, University of Dundee,
Dundee, United Kingdom
3 Clinical Practice Research Datalink (CPRD), MHRA, London, United Kingdom |
Publication(s): First published: 18 January 2020 https://doi.org/10.1002/cpt.1775
|
| Document Type(s): Abstract, Article, |
| Countries: France, Germany, UK, |
| Click here for the abstract |
C:
Y: |
Database Validity and methodology, Drug safety, Health policy,
2020 |
|
L:
A: |
English
Retrospective database analysis, |
|
|
| |
| |
| The Burden Of Hpv In Head And Neck Cancers - Design Of The Broaden Study |
| Author(s): Gómez Ulloa D1, Morais E2, Fenoll R1, Kothari S3, Giuliano A4, Mirghani H5, Mehanna H6, Waterboer T7, Roberts C3, Varga S3, Tu Y3, Pérez G3, Saah A3, Alemany L8 |
| Affiliations(s): 1 IQVIA, Barcelona, Spain 2 MSD, CORE, Lyon, France 3 Merck & Co. Inc., Center for Observational and Real-world Evidence, Kenilworth, NJ, US 4 Moffitt Cancer Center and Research Institute, Center for Immunization and Infection Research in Cancer, Tampa, FL, US 5 HEGP, ORL, Paris, France 6 InHANSE, Head and Neck Surgery, Birmingham, UK 7 German Cancer Research Center (DKFZ), Infections and Cancer Epidemiology, Heidelberg, Germany 8 Catalan Institute of Oncology - IDIBELL, On behalf of Unit of Cancer and Infection in the Cancer Epidemiology Research Programme, Hospitalet Del Llobregat, Spain |
Publication(s): IPVC, Barcelona, Spain, 23-27 March 2020
|
| Document Type(s): Oral presentation, |
| Countries: China, France, Germany, Italy, Japan, Portugal, Spain, |
C:
Y: |
Infectious disease, Oncology,
2020 |
|
L:
A: |
English
Burden of illness, Observational study, Retrospective Field Study, |
|
|
| |
| |
| Real-world clinical outcomes for third-line standard of care regimens in deficient mismatch repair (dMMR) or microsatellite instability high (MSI-H) metastatic colorectal cancer (mCRC) in France |
| Author(s): Cohen R1, Thierry A1, Roset M2, Amonkar M3, Patel R3, Lara N2, Kothari S3, Tougeron D4 |
| Affiliations(s): 1 Sorbonne Université, medical oncology department, AP-HP, hôpital Saint-Antoine, F-75012 Paris, France 2 IQVIA, Barcelona, Spain 3 Merck & Co, Inc., Kenilworth, NJ, US 4 Gastroenterology Department, Poitiers University Hospital and University of Poitiers, Poitiers, France |
Publication(s): ESMO GI, Barcelona, Spain 1-4 July 2020
|
| Document Type(s): Poster, |
| Countries: France, |
C:
Y: |
Oncology,
2020 |
|
L:
A: |
English
Observational study, Population Based Study, Retrospective Field Study, |
|
|
| |
| |
| The prevalence of polypharmacy and the use of potentially inappropriate medications (PIMs): a cross-national study in five European countries - Preliminary Results |
| Author(s): Bennie M1, Elseviers M2, Schubert I3, Poluzzi E4, MacBride S5, Sermet C6, Jouaville Abrouk LS7, Menon S7, Trehony J7, Nasuti P7, Taxis K8 |
| Affiliations(s): 1Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde / Information Services Division, NHS National Services Scotland, UK 2 Clinical Pharmacology, Ghent University, Belgium Centre for Innovation and Care, University of Antwerp, Belgium 3 PMV Research Group, Faculty of Medicine and University Hospital of Cologne, University for Cologne, Germany 4 University of Bologna, Italy 5 NHS Greater Glasgow and Clyde, Scotland 6 IRDES, Institut de Recherche en Economie de la Santé, France 7 IQVIA Real World Solutions, London, UK / France 8 University of Groningen, PharmacoTherapy, Epidemiology and Economics, Groningen, The Netherlands |
Publication(s): European Drug Utilisation Resarch Group (EuroDURG) Conference 2020, Szeged, Hungary, 4-7 March 2020
|
| Document Type(s): Poster, |
| Countries: Belgium, France, Germany, Italy, UK, |
C:
Y: |
Clinical practice, Public Health,
2020 |
|
L:
A: |
English
Population Based Study, Public Health, Retrospective database analysis, |
|
|
| |
| |
| Investigation of factors considered in the health technology assessment conducted by regulatory authority in eight countries |
| Author(s): Akira Yuasa 1, Naohiro Yonemoto 1, Sven Demiya 2, Chihiro Foellscher 2, Shunya Ikeda 3 (rwesheorj 2) |
| Affiliations(s): 1) Pfizer Japan Inc., Tokyo, Japan
2) IQVIA Solutions Japan, Tokyo, Japan
3) Graduate School of Medicine, International University of Health and Welfare, Tokyo, Japan |
Publication(s): ISPOR 2020 Conference
|
| Document Type(s): Abstract, |
| Countries: Australia, Canada, France, Germany, Italy, Japan, Spain, UK, |
| Click here for the abstract |
C:
Y: |
2020 |
|
L:
A: |
English
|
|
|
| |
| |
 2 of 36 
|
|
